Table 3 1-year changes in reported symptom distress between groups of morbidly obese patients undergoing RYGB (n=76) or intensive lifestyle intervention (n=63)
Symptom | RYGB | ILI | P | ES |
|---|---|---|---|---|
Physical stamina | −2.7 (2.5) | -.7 (2.6) | <.001 | .913 |
Pain in the joints | −2.4 (2.2) | -.7 (2.0) | .002 | .891 |
Snoring | −2.3 (2.2) | -. 8 (2.0) | .002 | .721 |
Sensitivity to cold | 1.4 (2.2) | .1 (1.9) | .005 | .921 |
Skin irritation | −1.2 (1.9) | -.3 (1.8) | .032 | .493 |
Sleep problems | −1.3 (2.2) | -.4 (2.2) | .043 | .406 |
Water retention | −1.5 (1.9) | -.6 (2.0) | .047 | .456 |
Foot problems | −2.2 (2.6) | −1.1 (2.5) | .050 | .541 |
Back pain | −1.6 (2.0) | -.9 (1.7) | .071 | .350 |
Tiredness | −1.6 (2.2) | -.7 (2.2) | .089 | .460 |
Shortness of breath | −2.2 (2.1) | −1.4 (1.9) | .093 | .442 |
Leakage of urine | -.8 (1.6) | -.3 (2.0) | .220 | .267 |
Frequent urination | -.8 (2.1) | -.3 (1.7) | .281 | .244 |
Increased sweating | −1.3 (2.1) | -.9 (2.2) | .339 | .246 |
Loss of sexual desire | −1.4 (2.6) | -.9 (2.6) | .393 | .215 |
Lightheadedness | .3 (1.8) | -.2 (1.5) | .517 | .164 |
Increased thirst | -.9 (1.9) | -.7 (1.8) | .569 | .136 |
Increased irritability | -.4 (2.1) | -.7 (2.1) | .595 | .140 |
Increased appetite | -.2 (2.2) | -.3 (2.0) | .849 | .044 |
Sensitivity to heat | −1.5 (2.4) | −1.6 (2.2) | .987 | .004 |